Colgate-Palmolive beats earnings forecasts as 11% jump in pricing offsets volume decline
Shares of Colgate-Palmolive Co. (CL) rose 0.9% in premarket trading Friday after the home, personal, oral and pet care products company reported second-quarter profit and revenue that beat expectations and raised its full-year outlook, as another jump in pricing helped offset a volume decline. Net income fell to $502 million, or 60 cents a share, from $603 million, or 72 cents a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share rose to 77 cents from 72 cents and beat the FactSet consensus of 75 cents. Sales rose 7.5% to $4.82 billion, above the FactSet consensus of $4.70 billion. Pricing increased 11.0%, after rising 12% a year ago, while volume fell 1.5% after being flat last year. For 2023, the company raised it guidance ranges for growth in EPS to the "high end" of mid-single-digits percentage range from mid-single-digits, and for growth in sales to 5% to 8% from 3% to 6%. The stock has lost 3.4% over the past three months through Thursday while the S&P 500 has gained 8.8%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-28-23 0711ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations